Background & Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), the causative agent of COVID-19 is a novel betacoronavirus that first appeared in Wuhan, Hubei Province, China in late December 2019. Real‐time reverse‐transcription polymerase chain reaction (RT‐ PCR) test has been routinely used as the diagnostic test to detect SARS‐ CoV‐2 nucleic acids in respiratory specimen swabs from throat, nasopharynx, and nose of individuals suspected of COVID‐19 during the acute phase of infection. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cycle threshold (Ct) has been suggested as an approximate measure of initial viral burden. So this study was undertaken retrospectively to evaluate association of CT values of patients tested positive for SARS CoV 2 by RT-PCR with clinical features and the outcomes of patients.